Afuco™ Anti-SUDV Ebola GP ADCC Therapeutic Antibody, ADCC Enhanced

Anti-Ebola GP ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies to Ebola GP can be used for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo.
Supplier Creative Biolabs
Product # AFC-210CL
Pricing Inquiry
Host Humanized
Target Ebola GP
Species Reactivity SUDV
Type ADCC enhanced antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Feedback